Insider Buying: Hawkins (NASDAQ:HWKN) CFO Buys $153,510.00 in Stock

Hawkins, Inc. (NASDAQ:HWKN) CFO Jeffrey Oldenkamp acquired 1,290 shares of Hawkins stock in a transaction that occurred on Thursday, August 27th. The shares were purchased at an average price of $119.00 per share, for a total transaction of $153,510.00. Following the completion of the purchase, the chief financial officer directly owned 104,223 shares of the company’s stock, valued at $12,402,537. The trade was a 1.25% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Hawkins Stock Up 1.4%

HWKN stock opened at $126.37 on Thursday. The firm has a market cap of $2.64 billion, a price-to-earnings ratio of 32.74, a PEG ratio of 2.53 and a beta of 0.77. Hawkins, Inc. has a 1-year low of $116.04 and a 1-year high of $186.15. The firm has a fifty day moving average price of $133.70 and a two-hundred day moving average price of $146.77. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.27 and a quick ratio of 1.54.

Hawkins (NASDAQ:HWKN) last posted its quarterly earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 EPS for the quarter, missing the consensus estimate of $1.39 by ($0.04). The business had revenue of $315.68 million during the quarter, compared to analyst estimates of $313.42 million. Hawkins had a net margin of 7.29% and a return on equity of 15.42%. Research analysts predict that Hawkins, Inc. will post 4.1 EPS for the current year.

Hawkins Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Friday, August 14th were given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, August 14th. Hawkins’s dividend payout ratio is presently 20.73%.

Hedge Funds Weigh In On Hawkins

Institutional investors have recently bought and sold shares of the stock. Values First Advisors Inc. lifted its stake in Hawkins by 0.8% during the first quarter. Values First Advisors Inc. now owns 9,855 shares of the specialty chemicals company’s stock valued at $1,514,000 after buying an additional 79 shares in the last quarter. Truist Financial Corp raised its holdings in shares of Hawkins by 4.7% during the fourth quarter. Truist Financial Corp now owns 1,852 shares of the specialty chemicals company’s stock valued at $263,000 after acquiring an additional 83 shares during the period. ProShare Advisors LLC lifted its position in shares of Hawkins by 3.0% in the 4th quarter. ProShare Advisors LLC now owns 3,815 shares of the specialty chemicals company’s stock valued at $542,000 after acquiring an additional 112 shares in the last quarter. Quantinno Capital Management LP boosted its stake in Hawkins by 0.9% in the 2nd quarter. Quantinno Capital Management LP now owns 13,618 shares of the specialty chemicals company’s stock worth $1,935,000 after purchasing an additional 124 shares during the period. Finally, Sanctuary Advisors LLC grew its position in Hawkins by 6.1% during the 1st quarter. Sanctuary Advisors LLC now owns 2,371 shares of the specialty chemicals company’s stock worth $364,000 after purchasing an additional 137 shares in the last quarter. Hedge funds and other institutional investors own 69.71% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on HWKN shares. Barclays set a $142.00 price target on Hawkins and gave the company an “equal weight” rating in a research report on Friday, July 31st. Zacks Research cut shares of Hawkins from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 4th. BWS Financial restated a “buy” rating and set a $200.00 price objective on shares of Hawkins in a research report on Monday, August 3rd. Finally, Weiss Ratings cut shares of Hawkins from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, August 27th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $171.00.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.